ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nanoassembly of doxorubicin-conjugated polyphosphoester and siRNA simultaneously elicited macrophage- and T cell- mediated anticancer immune response for cancer therapy

Li, Dongdong; Cao, Ziyang; Chen, Chaoran; Li, Hengyi; He, Shan; Hou, Xurui; Liang, Ming*; Yang, Xianzhu*; Wang, Jun*北京化工大学; 1
Biomaterials2023-11DOI: 10.1016/j.biomaterials.2023.122339
3被引8阅读
引用收藏
分享

摘要

Efficiently reawakening immune cells, including T cells and macrophages, to eliminate tumor cells is a promising strategy for cancer treatment, but remains a huge challenge nowadays. Herein, a nanoassembly formed by doxorubicin (DOX)-conjugated polyphosphoester (PP-(hDOX)) and CD47-targeting siRNA (siCD47) via electro-static and 7C -7C stacking interactions, termed as PP-(hDOX&siCD47), was developed to reawaken the T cell and macrophage-mediated anticancer activity. The PP-(hDOX&siCD47) could efficiently blockade antiphagocytic signal by downregulation of CD47 expression to reactive macrophage-mediated anticancer immunotherapy. Moreover, the conjugated DOX of PP-(hDOX&siCD47) can perform the chemotherapy towards tumor cells and also elicit the T cell-mediated anticancer immune response via immunogenic cell death (ICD) effect. Therefore, the PP-(hDOX&siCD47) treatment could significantly increase M1-like macrophages proportion and tumor infiltration of CD8+ T cells, while the proportions of regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSC) were considerably reduced in tumor tissue, eventually achieving significantly tumor growth inhibition. Overall, this study provides a simple siRNA and DOX codelivery approach to simultaneously elicit the macrophage-and T cell-mediated anticancer immune response for cancer therapy.

学科与关键词

关键词
DOX conjugatesiRNA delivery systemBlockade CD47 signalActivate ICD effectChemo-immunotherapy
相关
加载中…
  • Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy
    Luo, Jia-Qi; Liu, Rong; Chen, Fang-Man; Zhang, Jing-Yang; Zheng, Sui-Juan; Shao, Dan; Du, Jin-Zhi*ACS Nano, 2023, 17(10): 8966-8979.被引 14
  • Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression
    Chen, Senbiao; Li, Dongdong; Du, Xiaojiao*; He, Xinyu; Huang, Mengwen; Wang, Yang; Yang, Xianzhu*; Wang, Jun*Nano Today, 2020, 35: 100924.被引 72
  • A siRNA-Assisted Assembly Strategy to Simultaneously Suppress "Self" and Upregulate "Eat-Me" Signals for Nanoenabled Chemo-Immunotherapy
    Zhang, Yuxi; Zhang, Zhenghai; Li, Senlin; Zhao, Liang; Li, Dongdong; Cao, Ziyang; Xu, Xiaoding; Yang, Xianzhu*ACS Nano, 2021, 15(10): 16030-16042.被引 41
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomaterials
发表日期
2023-11
卷期
第 302 卷
页码
122339
DOI
10.1016/j.biomaterials.2023.122339
语言
ENGLISH
成果收录
SCIE
资助标注
National Key R & D Program of China [2022YFC3401400]; National Natural Science Foundation of China [U22A20156, 52173121, 82170761, 52303181]; Guangdong Basic and Applied Basic Research Foundation [2021A1515110934, NCTIB2022HS01012]; Open Project of Guangdong Province Key Laboratory of Biomedical Engineering [GDKLBEM202203]

作者

  • L

    Li, Dongdong (第一作者)

    1

  • C

    Cao, Ziyang

    1

查看全部 9 位作者收起作者
  • C

    Chen, Chaoran

  • L

    Li, Hengyi

    1

  • H

    He, Shan

  • H

    Hou, Xurui

    beijing univ chem technol

  • L

    Liang, Ming (通讯)

    1

  • Y

    Yang, Xianzhu (通讯)

  • W

    Wang, Jun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417